Access peer-reviewed studies, experimental data, and scientific analysis on viral pathogens
Explore how direct-acting antivirals (DAAs) are transforming hepatitis C treatment for patients with chronic kidney disease, achieving cure rates exceeding 95% even in end-stage renal disease.